2002
DOI: 10.1118/1.1510452
|View full text |Cite
|
Sign up to set email alerts
|

Experimental determination of dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of ‐model Pd‐1

Abstract: A newly designed encapsulated 103Pd source has been introduced (BrachySeed-Pd-103, also named Model Pd-1, manufactured by DRAXIMAGE Inc. and distributed by Cytogen Corp.) for interstitial brachytherapy to provide more isotropic dose distributions. In this work, the dosimetric characteristics of the 103Pd source were measured with micro LiF TLD chips and dosimetry parameters were characterized based upon the American Association of Physicists in Medicine (AAPM) Task Group No. 43 formalism. The dose rate constan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2004
2004
2009
2009

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 5 publications
0
4
0
Order By: Relevance
“…Seed dimensions for the LS-1 seed [38][39][40][41][42] are the same as those used in the study by Williamson. 38 The DRAXIMAGE BrachySeed LS-1 consists of two 0.500 mm diameter aluminum silicate spheres containing a uniform distribution of 125 I. Density of the aluminum silicate is 2.81 g / cm 3 and composition by weight is 40.7% O, 21.4% Si, 16.6% Al, 11.3% Na, and 10.0% Ag 38 ͑the amount of 125 I within the spheres is assumed to be negligible͒.…”
Section: Iiia8 Draximage Brachyseed Ls-1mentioning
confidence: 99%
See 1 more Smart Citation
“…Seed dimensions for the LS-1 seed [38][39][40][41][42] are the same as those used in the study by Williamson. 38 The DRAXIMAGE BrachySeed LS-1 consists of two 0.500 mm diameter aluminum silicate spheres containing a uniform distribution of 125 I. Density of the aluminum silicate is 2.81 g / cm 3 and composition by weight is 40.7% O, 21.4% Si, 16.6% Al, 11.3% Na, and 10.0% Ag 38 ͑the amount of 125 I within the spheres is assumed to be negligible͒.…”
Section: Iiia8 Draximage Brachyseed Ls-1mentioning
confidence: 99%
“…The source dimensions for the Pd-1 seed [71][72][73] are taken from the study by Chan and Prestwich. 73 The DRAXIMAGE BrachySeed Pd-1 source consists of two 0.55 mm diameter aluminum silicate spheres containing a uniform distribution of 103 Pd ͑spheres have a density of 2.53 g / cm 3 and the composition by weight 73 is 45.2% O, 23.8% Si, 18.4% Al, and 12.6% Na with a negligible amount of 103 Pd͒.…”
Section: Iiib3 Draximage Brachyseed Pd-1mentioning
confidence: 99%
“…(1,2) The TG-43 protocols have been extensively used to determine the dosimetric characteristics of various source types and models with a Corresponding author: Ali S. Meigooni, University of Kentucky, Department of Radiation Medicine, Lexington, KY, U.S.A.; phone: 859-323-6487; fax: 859-257-1211; email: alimeig@email.uky.edu active lengths of 1.0 cm or less. (3)(4)(5)(6)(7)(8)(9) The original TG-43 protocol, introduced in 1995, was based on recommendations of the Interstitial Collaborative Working Group (10) and provided limited published dosimetric data. Their data included 125 I [models 6711 and 6702 (Amersham/ Oncura, Plymouth Meeting, PA)], 103 Pd [model 200 (Theragenics Corporation, Norcross, GA)], and 192 Ir (Best Industries, Springfield, VA) sources.…”
Section: Introductionmentioning
confidence: 99%
“…[3][4][5] Due to this fact, several investigators have presented F͑r , ͒, mainly for the TG-43U1 recommended minimal radial distances. [6][7][8] However, for elongated photon emitting brachytherapy sources ͑active length Ͼ1.0 cm͒ such as RadioCoil™ 103 Pd 9 and 137 Cs tubes, the variation of the 2D anisotropy function with radial distance has not been evaluated.…”
Section: Introductionmentioning
confidence: 99%